Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

CIKRIKCIOGLU M. A., OZDEMIR A. A., SEKIN Y., YALCIN B., ALTAY M., GUNDOGDU A., ...Daha Fazla

MINERVA UROLOGICA E NEFROLOGICA, cilt.67, sa.3, ss.187-196, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 67 Sayı: 3
  • Basım Tarihi: 2015
  • Dergi Adı: MINERVA UROLOGICA E NEFROLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.187-196
  • Anahtar Kelimeler: Calcium, antagonists and inhibitors, Angiotensin-converting enzyme inhibitors, Anemia, Hemodialysis, Hemoglobin, ERYTHROPOIETIN RESISTANCE, KIDNEY-DISEASE, VALIDATION, TRPC2
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Aim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.